Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Methamphetamine (METH) use disorder (MUD) is a public health catastrophe. Herein, we used a METH self-administration model to assess behavioral responses to the dopamine receptor D1 (DRD1) antagonist, SCH23390. Differential gene expression was measured in the dorsal striatum after a 30-day withdrawal from METH. SCH23390 administration reduced METH taking in all animals. Shock Resistant (SR) rats showed greater incubation of METH seeking, which was correlated with increased , , and mRNA expression. Cytoplasmic polyadenylation element binding protein 4 () mRNA levels were increased in shock-sensitive (SS) rats. SS rats also showed increased protein levels for cleavage and polyadenylation specificity factor (CPSF) and germ line development 2 (GLD2) that are CPEB4-interacting proteins. Interestingly, GLD2-regulated GLUN2A mRNA and its protein showed increased expression in the shock-sensitive rats. Taken together, these observations identified CPEB4-regulated molecular mechanisms acting via NMDA GLUN2A receptors as potential targets for the treatment of METH use disorder.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11942873 | PMC |
| http://dx.doi.org/10.3390/ijms26062734 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
D1-like dopamine receptors in the dentate gyrus mediate cannabidiol's facilitation of extinction and prevention of reinstatement in methamphetamine-induced conditioned place preference.
Pharmacol Biochem Behav
September 2025
Neuroscience Research Center, Institute of Neuroscience and Cognition, Shahid Beheshti University of Medical Sciences, Tehran, Iran; School of Cognitive Sciences, Institute for Research in Fundamental Sciences, Tehran, Iran; Department of Basic Sciences, Iranian Academy of Medical Sciences, Tehran,
Methamphetamine (METH) is a highly addictive psychostimulant, and despite its widespread abuse, there are no FDA-approved treatments for METH use disorder (MUD). Cannabidiol (CBD), a non-psychoactive cannabinoid, has shown promise in reducing behaviors linked to psychostimulant use, including METH. However, the underlying neurobiological mechanisms remain unclear.
View Article and Find Full Text PDF[Microglia-mediated cognitive impairment induced by methamphetamine].
Nihon Yakurigaku Zasshi
August 2025
Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama.
More than half of chronic methamphetamine (METH) users exhibit multi-domain cognitive deficits, including impaired attention, executive function, and memory. MRI studies consistently demonstrate hippocampal atrophy and frontotemporal cortical thinning; these structural changes spatially overlap with glial activation, indicating the coexistence of morphological damage and ongoing neuroinflammation. To clarify causality, we developed a mouse model in which low-dose METH is micro-infused into the nucleus accumbens.
View Article and Find Full Text PDFDisrupted betaine metabolism drives Th17 cell differentiation, mediating methamphetamine-induced depressive behaviors in male mice.
J Neuroinflammation
August 2025
College of Forensic Medicine, Hebei Key Laboratory of Forensic Medicine, Collaborative Innovation Center of Forensic Medical Molecular Identification, Hebei Medical University, Shijiazhuang, Hebei Province, 050017, China.
Unlabelled: Methamphetamine (METH) abuse, a global public health concern, is closely linked to neuropsychiatric disorders such as depression. Although the central nervous system (CNS) damage induced by METH is well documented, the role of peripheral immune mechanisms remains underexplored. To investigate this, we establish a depressive-like mouse model in male mice using repeated intraperitoneal METH injections.
View Article and Find Full Text PDFPsychostimulants and the cerebellum: Does the cerebellum get involved in the abuse of methamphetamine and cocaine?
Prog Neuropsychopharmacol Biol Psychiatry
August 2025
Department of Physiology, Kerman University of Medical Sciences, Kerman Neuroscience Research Center, Kerman, Iran. Electronic address:
Clinical evidence suggests that the cerebellum is one of the brain areas most vulnerable to the effects of psychostimulants. Functional neuroimaging studies support the idea that the cerebellum is involved in the neural circuits affected by these drugs. The cerebellum plays a vital role in the brain's reward mechanisms, working in conjunction with the striatum, ventral tegmental area (VTA), and prefrontal cortex (PFC).
View Article and Find Full Text PDFExpanding the Public Health Role of Pediatric Trauma Centers: Drug Screening for Adolescent Trauma Patients.
J Am Coll Surg
August 2025
Division of Pediatric Surgery, Children's Hospital Los Angeles, Los Angeles, CA.
Background: Injury and overdose are leading causes of adolescent death in the United States, with high rates of problematic substance use among injured adolescents. We sought to determine whether drug screening prevalence and positivity at pediatric trauma centers have changed with the ongoing adolescent overdose crisis.
Study Design: This study evaluated trends in biochemical drug screening prevalence and positivity among injured adolescents (12-17 years) from the 2017-2022 Trauma Quality Improvement Program dataset.